Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1289446 | 0.95 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL5342682 | 0.93 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL49611 | 0.87 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL8636707 | 0.87 | ALDH1A1 (0.38) | ALDH1A1 | |
| SCHEMBL4582447 | 0.86 | — | — | |
| Water SCHEMBL28119346 | 0.85 | ALDH1A1 (0.36) | ALDH1A1 | |
| SCHEMBL15841370 | 0.84 | ALDH1A1 (0.32) | ALDH1A1 | |
| SCHEMBL6564179 | 0.83 | ALDH1A1 (0.35) | ALDH1A1 | |
| Ammonia Solution, Strong SCHEMBL28183813 | 0.83 | ALDH1A1 (0.35) | ALDH1A1 | |
| Acetone SCHEMBL9580337 | 0.82 | ALDH1A1 (0.38) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 330 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624168-B2 | Methods for making polyfunctional organosiloxanes and compositions containing same | DOW SILICONES CORPORATION (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4519346-B1 | SILICONE-POLYETHER COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORP (US) | 2026-01-14 | — | — | EP | disclosed |
| US-12497509-B2 | Method for manufacturing a silicone elastomer article using a 3D printer | ELKEM SILICONES FRANCE SAS (FR) | 2025-12-16 | — | — | US | disclosed |
| EP-3645607-B1 | METHOD FOR HYDROSILYLATION OF ALIPHATICALLY UNSATURATED ALKOXYSILANES AND HYDROGEN TERMINATED ORGANOSILOXANE OLIGOMERS TO PREPARE ALKOXYSILYL TERMINATED POLYMERS USEFUL FOR FUNCTIONALIZING POLYORGANOSILOXANES USING AN IRIDIUM CATALYST | DOW SILICONES CORP (US) | 2025-11-05 | — | — | EP | disclosed |
| US-12441844-B2 | Methods for making polyfunctional organosiloxanes and compositions containing same | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-10-14 | — | — | US | disclosed |
| US-12428561-B2 | Silicone-polyether copolymer, sealants comprising same, and related methods | DOW SILICONES CORPORATION (US) | 2025-09-30 | — | — | US | disclosed |
| US-12378264-B2 | Multifunctional organosilicon compound and related methods, compounds, and compositions | DOW SILICONES CORPORATION (US) | 2025-08-05 | — | — | US | disclosed |
| US-12344712-B2 | Silicone-poly acrylate copolymer, sealants comprising same, and related methods | DOW SILICONES CORPORATION (US) | 2025-07-01 | — | — | US | disclosed |
| EP-3898782-B1 | SILICONE-POLYACRYLATE COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORP (US) | 2025-06-25 | — | — | EP | disclosed |
| US-20250109292-A1 | SILICONE-POLYETHER COPOLYMER, SEALANTS COMPRISING SAME, AND RELATED METHODS | DOW SILICONES CORPORATION | 2025-04-03 | — | — | US | disclosed |
| WO-2013009840-A1 | LANTHANIDE COMPLEXES WITH IMIDAZOLE LIGANDS FOR CONDENSATION REACTIONS | DOW CORNING CORPORATION (US) | 2013-01-17 | — | — | WO | disclosed |
| WO-2012134784-A1 | COMPOSITIONS CONTAINING PHOSPHONATE CATALYSTS AND METHODS FOR THE PREPARATION AND USE OF THE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012134786-A1 | COMPOSITIONS CONTINING SULFONIC ACID CATALYSTS AND METHODS FOR THE PREPARATION AND USE OF THE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012134788-A1 | COMPOSITIONS CONTAINING PHOSPHATE CATALYSTS AND METHODS FOR THE PREPARATION AND USE OF THE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012047312-A1 | BIODEGRADABLE HYDROPHOBIC CELLULOSIC SUBSTRATES AND METHODS FOR THEIR PRODUCTION USING REACTIVE SILANES | DOW CORNING CORPORATION (US) | 2012-04-12 | — | — | WO | disclosed |
| US-8142856-B2 | Preparing hydrolyzate containing polysiloxanes by hydrolyzing hydrolysable silane or hydrolysable silane mixture in presence of acid hydrolysis catalyst andcombining polysiloxane hydrolyzate with mineral and/or filler and optionally with water and/or a catalyst for condensation of the hydrolyzate | DOW CORNING CORPORATION (US) | 2012-03-27 | — | — | US | disclosed |
| US-20080286474-A1 | Hydrophobing Minerals and Filler Materials | DOW SILICONES CORPORATION | 2008-11-20 | — | — | US | disclosed |
| EP-1904415-A2 | HYDROPHOBING MINERALS AND FILLER MATERIALS | Dow Corning Corporation (US) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007009935-A2 | HYDROPHOBING MINERALS AND FILLER MATERIALS | DOW CORNING CORPORATION (US) | 2007-01-25 | — | — | WO | disclosed |
| US-5663265-A | FREE RADICAL COPOLYMERIZATION FOR COATINGS | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12378264-B2 | Multifunctional organosilicon compound and related methods, compounds, and compositions | MSR1, OXSR1, RIOX2 | ALDH1A1 1749/4885 |
| US-12624168-B2 | Methods for making polyfunctional organosiloxanes and compositions containing same | HAO2, H1-2, HRH2 | ALDH1A1 596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.